0.43
Schlusskurs vom Vortag:
$0.27
Offen:
$0.2941
24-Stunden-Volumen:
105.36K
Relative Volume:
20.49
Marktkapitalisierung:
$N/A
Einnahmen:
$18.10M
Nettoeinkommen (Verlust:
$-16.56M
KGV:
-0.4497
EPS:
-0.9561
Netto-Cashflow:
$-7.45M
1W Leistung:
+53.90%
1M Leistung:
+53.90%
6M Leistung:
-67.91%
1J Leistung:
+3.84%
Marpai Inc Stock (MRAI) Company Profile
Compare MRAI vs UNH, CVS, ELV, CI, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
MRAI
Marpai Inc
|
0.43 | 0 | 18.10M | -16.56M | -7.45M | -0.9561 |
|
UNH
Unitedhealth Group Inc
|
376.86 | 352.79B | 449.71B | 12.81B | 19.67B | 13.24 |
|
CVS
Cvs Health Corp
|
90.73 | 118.99B | 407.94B | 2.90B | 7.39B | 2.2771 |
|
ELV
Elevance Health Inc
|
387.85 | 85.71B | 200.42B | 5.24B | 6.45B | 23.50 |
|
CI
Cigna Group
|
280.83 | 75.72B | 278.13B | 6.74B | 7.66B | 23.60 |
|
HUM
Humana Inc
|
301.69 | 36.97B | 137.20B | 1.15B | 1.27B | 9.3439 |
Marpai Inc Aktie (MRAI) Neueste Nachrichten
Marpai secures 192,000 new member lives, projects profitability - Investing.com
Marpai Inc. Announces Unprecedented Growth with 192,000 New Estimated Member Lives Across TPA and MarpaiRx PBM Platforms; Expects to Achieve Positive Cash Flow and EBITDA Beginning August 2026 - Morningstar
Marpai (MRAI) director Eitan Yaron adds 10,000 shares in open-market buy - Stock Titan
MARPAI reports net loss of USD 3.2M in Q1 2026 - Medical Buyer
Marpai reports Q1 2026 results with cloud migration nearing completion and targets profitability in H2 2026 - Pluang
Marpai reports Q1 loss, targets second-half profitability - Investing.com
Marpai reports Q1 loss, targets second-half profitability By Investing.com - Investing.com Nigeria
Marpai (MRAI) Q1 2026 shows losses, heavy debt and going concern risk - Stock Titan
BRIEF-Marpai Q1 Revenue USD 4.4 Million - TradingView
MARPAI REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS - TradingView
Marpai, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Marpai secures major new contracts, boosting path to profitability with integrated healthcare services. - Pluang
Marpai, Inc. Secures New Contracts for TPA and MarpaiRx Services - marketscreener.com
Marpai Extends Maturity of Insider Promissory Notes - TipRanks
Marpai (MRAI) pushes $660,000 CEO promissory notes out to Sept. 1, 2026 - Stock Titan
Marpai, Inc. (MRAI) - Minichart
Marpai (MRAI) director receives 100,000 RSUs tied to strategic deal - Stock Titan
Marpai, Inc. Secures Major Strategic Marketing Collaboration to Continue Acceleration of MarpaiRx Growth Nationwide - PR Newswire
Marpai, Inc. Empowers Self-Insured Employers With AI-Driven TPA Services, Cost Savings, and Healthcare Solutions - Minichart
Marpai 2025 10-K: Revenue $18.1M, EPS $(0.95) - TradingView
Marpai, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
Marpai Inc. (MRAI) warns of going concern risk and OTCQX trading shift - Stock Titan
Marpai, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Marpai (NASDAQ:MRAI) Stock Price Down 3.9% – Here’s Why - Defense World
Marpai Secures CEO Loan to Bolster Near-Term Liquidity - The Globe and Mail
Marpai enters $250,000 loan agreement with CEO Damien Lamendola - Investing.com India
Marpai, Inc. Files Form 8-K Announcing Promissory Note Dated March 9, 2026 - Minichart
Marpai Raises $250,000 Via 12% Promissory Note From CEO, Maturing May 10, 2026 - TradingView
CEO lends $250K to Marpai (OTCQX: MRAI) in short-term note - Stock Titan
Marpai, Inc. Enters Marketing Agreement To Expand MarpaiRx National Distribution Channel - marketscreener.com
Marpai Secures Access to Network Creating Major Growth Catalyst for MarpaiRx Representing Up to 1.5 million Covered Lives - PR Newswire
Marpai, Inc. announced that it has received $0.25 million in funding - marketscreener.com
Intelligent Fanatics, Ian Cassel report 4.4% stake in Marpai (MRAI) - Stock Titan
MRAI SEC FilingsMarpai Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Marpai (NASDAQ:MRAI) Shares Up 15.2% – Time to Buy? - defenseworld.net
MRAI Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Marpai, Inc. Secures Major Strategic Wins for MarpaiRx, Adding Over 19,000 Lives and Accelerating High-Growth Platform Expansion - ChartMill
Marpai Secures Insider Promissory Note for Working Capital - TipRanks
Marpai Signs Promissory Note With Damien Lamendola - TradingView
Marpai’s Strategic Moves Under Investor Scrutiny - AD HOC NEWS
Marpai, Inc. announced that it has received $0.41 million in funding - marketscreener.com
Marpai hires Mimi Davis as president of MarpaiRx to drive growth - Investing.com Australia
MARPAI, INC. HIRES PHARMACY EXECUTIVE MIMI DAVIS AS PRESIDENT OF MARPAIRX TO DRIVE STRATEGIC GROWTH - PR Newswire
Marpai consolidates leadership as CEO Damien Lamendola becomes President - The Globe and Mail
Marpai, Inc. Announces President Changes, Effective January 30, 2026 - marketscreener.com
MARPAI ANNOUNCES 2026 MOMENTUM and KEY PARTNERSHIP EXPANSION - marketscreener.com
Marpai, Inc. (NASDAQ: MRAI) gets 5.6% ownership filing from IFCM fund - Stock Titan
January 2026 Board Member SpotlightSteve Johnson - Financial Executives International
Marpai Announces New Equity Financing and Warrant Agreement - TipRanks
Marpai Signs Securities Purchase Agreement With Certain Investors - TradingView — Track All Markets
Marpai (OTCQX: MRAI) sells shares and warrants in $350,000 private deal - Stock Titan
Finanzdaten der Marpai Inc-Aktie (MRAI)
Umsatz
Nettogewinn
Free Cashflow
ENV
Kapitalisierung:
|
Volumen (24h):